TOT Biopharm Overview
- Founded
-
2010
- Status
-
Public
- Employees
-
355
- Stock Symbol
-
01875
- Share Price
-
$0.38
- (As of Monday Closing)
TOT Biopharm General Information
Description
TOT Biopharm International Co Ltd is a clinical-stage biopharmaceutical company dedicated to developing and commercializing oncology drugs and therapies for patients and their families as well as medical professionals. The company has a comprehensive portfolio of drugs under development for various types of cancer, including a variety of monoclonal antibody drugs, antibody-conjugated ADCs, and special oncology drugs. It generates revenues from China.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
HKG
Primary Office
- 120 Changyang Street
- Suzhou Industrial Park
- Suzhou, 215024
- China
+86 0512 0000 0000
TOT Biopharm Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.38 | $0.38 | $0.31 - $0.61 | $292M | 765M | 53.6K | -$0.04 |
TOT Biopharm Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 258,092 | 324,199 | 292,687 | 416,073 |
| Revenue | 36,403 | 11,820 | 3,256 | 6,557 |
| EBITDA | (24,298) | (34,920) | (37,141) | (39,269) |
| Net Income | (25,062) | (40,454) | (41,759) | (43,316) |
| Total Assets | 121,203 | 111,430 | 98,141 | 145,404 |
| Total Debt | 36,876 | 32,721 | 1,134 | 10,730 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
TOT Biopharm Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
TOT Biopharm Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
TOT Biopharm International Co Ltd is a clinical-stage biopharmaceutical company dedicated to developing and commercializ
Drug Discovery
Suzhou, China
355
As of 2022
00000
0000
0000-00-00
00000000
00000
000000
ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in
000000000000000
Foster City, CA
00000
As of 0000
00.000
000000000
00.000
000000
eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud e
0000000000000
Boston, MA
00
As of 0000
00000
0000000000 0
00000
Add Comparison
TOT Biopharm Competitors (11)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Gilead Sciences | Formerly VC-backed | Foster City, CA | 00000 | 00.000 | 000000000 | 00.000 |
| 000000000 000000 | Venture Capital-Backed | Boston, MA | 00 | 00000 | 0000000000 0 | 00000 |
| 000000 | Formerly VC-backed | Cambridge, MA | 0000 | 000.00 | 000000&0 | |
| 00000 | Corporation | Basel, Switzerland | 000000 | 00.000 | 00000000000 | 00.000 |
| 00000000 | Corporation | Berkeley Heights, NJ | 00 | 000.00 | 000000&0 |
TOT Biopharm Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Rongjin Lin | TOT Biopharm | Chairman | 000 0000 |
TOT Biopharm Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
TOT Biopharm Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
TOT Biopharm Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 0000000 0000000000 | Biotechnology | Suzhou, China | 0000 |